Cipla to ink marketing pact with Serum Institute: Report

06 Feb 2015 Evaluate

Cipla is reportedly planning to ink marketing pact with Pune-based unlisted Serum Institute. According to the agreement, Cipla will sell Serum’s products in Europe and Africa.

Serum is one of the world’s biggest producers of vaccines and is unlisted. In the last few years, Cipla has strengthened its distribution in Africa by buying a company in South Africa and is planning to raise overseas contribution to its revenues to 80%.

Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 170 countries. Its portfolio includes 2000 products in 65 therapeutic categories with one quality standard globally.

Cipla Share Price

1520.55 -0.65 (-0.04%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×